{"id":"NCT02207634","sponsor":"Amgen","briefTitle":"Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects","officialTitle":"A Double-Blind, Placebo Controlled, Multicenter Study to Assess the Effect of Evolocumab on Cognitive Function in Patients With Clinically Evident Cardiovascular Disease and Receiving Statin Background Lipid Lowering Therapy: A Study for Subjects Enrolled in the FOURIER (Study 20110118) Trial","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-09-10","primaryCompletion":"2016-11-11","completion":"2016-11-11","firstPosted":"2014-08-04","resultsPosted":"2018-01-16","lastUpdate":"2018-01-16"},"enrollment":1974,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"OTHER"},"conditions":["Dyslipidemia"],"interventions":[{"type":"BIOLOGICAL","name":"Evolocumab","otherNames":["AMG 145","Repatha"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Background Statin Therapy","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Evolocumab","type":"EXPERIMENTAL"}],"summary":"This study evaluated change over time in neurocognitive testing in patients receiving statin therapy in combination with evolocumab (AMG 145), compared with patients receiving statin therapy in combination with placebo.","primaryOutcome":{"measure":"Mean Change From Baseline in Spatial Working Memory Strategy Index of Executive Function (6-8 Boxes) Z Score","timeFrame":"Assessments were conducted at Baseline and at weeks 24, 48, 96, 144 and end of study visit (median time on study was 19.4 months).","effectByArm":[{"arm":"Placebo","deltaMin":0.1206,"sd":null},{"arm":"Evolocumab","deltaMin":0.1134,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":416,"countries":["United States","Australia","Belgium","Canada","Czechia","Denmark","Estonia","Finland","France","Germany","Greece","Hong Kong","Hungary","Italy","Japan","Latvia","Lithuania","Malaysia","Netherlands","New Zealand","Norway","Poland","Portugal","Russia","Slovakia","South Africa","Spain","Sweden","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["28207168","28813214","33078867"],"seeAlso":["http://www.amgentrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":204,"n":990},"commonTop":["Nasopharyngitis","Hypertension","Upper respiratory tract infection","Diabetes mellitus","Back pain"]}}